Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Chudik

Orthopaedic Surgery Westmont, IL Medical Doctor

NPI 1215029210 CMS profile 100020

1010 Executive Dr, Suite 250, Westmont, IL 60559

Open in the dashboard

General payments

$4,058,044

153 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$50,000

1 holding reported · through program year 2025

Through program year 2025, Steven Chudik of Westmont, IL is reported in the CMS Open Payments database as having received $4,058,044 across 153 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $50,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $83,167 22
2024 General $29,185 28
2023 General $2,408,133 8
2022 General $838 8
2021 General $110,863 23
2020 General $813,149 23
2019 General $612,709 41
2025 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Chudik
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Steven Chudik were reported at $83,167. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Steven Chudik Orthopaedic Surgery median Middle half National median
2019 $612,709 $644 $140–$2,844 $163
2020 $813,149 $312 $75–$1,860 $114
2021 $110,863 $520 $117–$2,495 $132
2022 $838 $598 $128–$2,731 $149
2023 $2,408,133 $461 $128–$2,264 $160
2024 $29,185 $497 $134–$2,475 $164
2025 $83,167 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $3,987,592 83 payments
  2. DePuy Synthes Products, Inc. $54,069 40 payments
  3. Medical Device Business Services, Inc. $10,526 10 payments
  4. Medwest Associates $3,308 4 payments
  5. Exactech, Inc. $1,424 3 payments
  6. Wright Medical Technology, Inc. $724 2 payments
  7. DePuy Synthes Sales Inc. $189 4 payments
  8. Zimmer Biomet Holdings, Inc. $69 1 payment
  9. Pacira Pharmaceuticals Incorporated $45 2 payments
  10. Solventum Corporation $35 1 payment
  11. Other $62 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $3,940,313 24 payments
  2. Consulting Fee $104,953 34 payments
  3. Travel and Lodging $6,507 31 payments
  4. Education $3,308 4 payments
  5. Food and Beverage $2,319 59 payments
  6. Gift $644 1 payment
Products named General payments · program years 2019–2025
  1. SHOULDER INSTRUMENTS SUTURE PASSING DISPOSABLES LASSOS $869,581 12 payments
  2. ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE PARTIAL ECLIPSE $790,317 10 payments
  3. KNEE & HIP INSTRUMENTS ACL/PCL DISPOSABLES GUIDE PINS $696,556 5 payments
  4. SHOULDER INSTRUMENTS ANCHOR SPECIFIC INSTRUMENTS OTHER $696,556 5 payments
  5. SHOULDER INSTRUMENTS CANNULAS RIGID $696,556 5 payments
  6. ARTHROPLASTY INSTRUMENTS ANATOMIC TOTAL SHOULDER PARTIAL ECLIPSE & BIOTSR $528,561 2 payments
  7. ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE PARTIAL ECLIPSE $509,263 5 payments
  8. SHOULDER INSTRUMENTS ANCHOR SPECIFIC INSTRUMENTS PUSHLOCKS $186,117 8 payments
  9. SHOULDER INSTRUMENTS ANCHOR SPECIFIC INSTRUMENTS SUTURETAKS $135,613 5 payments
  10. SHOULDER INSTRUMENTS OTHER INSTRUMENTS INSTRUMENT SETS $67,277 2 payments
  11. Other $325,318 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$76,252

Of which drugs: $936

Medicare patients

144

Average age 70

Services billed

1,092

73 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 63%
High blood pressure 56%
Ischemic heart disease 24%
Osteoporosis 16%
Diabetes 15%
Cancer 15%
Depression 15%
Chronic kidney disease 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 51 285 $198

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

153 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record